MFN2 and liver cancer: Hepatic MFN2 deficiency reduces the transfer of PS at EMCS which leads to a decrease in PS synthesis and ER stress, consequently causing inflammation, fibrosis and liver cancer (Hernández-Alvarez et al., 2019).